Level 2 - Details on Drug-resistant Tuberculosis

• 1. What is tuberculosis and why is it a concern?
• 2. What is the Global Project on Anti-tuberculosis Drug Resistance Surveillance?
• 3. What are current trends in drug-resistant tuberculosis?
  • 3.1 How many people are affected by drug-resistant tuberculosis?
  • 3.2 How do trends vary from region to region?
  • 3.3 How common is extensively drug-resistant tuberculosis?
• 4. Why do HIV and tuberculosis form a lethal combination?
• 5. What is the status of drug-resistant tuberculosis in the different WHO regions?
  • 5.1 The African WHO Region
  • 5.2 The North and South American WHO Region
  • 5.3 The Eastern Mediterranean WHO Region
  • 5.4 The European WHO Region
  • 5.5 The South East Asia WHO Region
  • 5.6 The Western Pacific WHO Region
• 6. Why is it difficult to gather information on drug-resistant tuberculosis?
• 7. Conclusions
  • 7.1 Magnitude and trends of drug-resistant tuberculosis
  • 7.2 Extensively drug-resistant tuberculosis (XDR-TB)
  • 7.3 Drug-resistant tuberculosis and HIV
  • 7.4 Survey coverage and methods
  • 7.5 Tuberculosis control and drug-resistant tuberculosis